Evidence map›Paper›PMID 35368085›Full record

ArticleProtein engineering, design & selection : PEDS2022

Correction to: Protease-stable DARPins as promising oral therapeutics.

Rudo A Simeon, Yu Zeng, Vikas Chonira, Andrea Martinez Aguirre, Mauricio Lasagna, Marko Baloh, Joseph A Sorg, Cecilia Tommos, Zhilei Chen

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Protein engineering, design & selection : PEDS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Rudo A SimeonDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, 8847 Riverside Pkwy, Bryan, TX 77807, USA.
Yu ZengDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, 8847 Riverside Pkwy, Bryan, TX 77807, USA.
Vikas ChoniraDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, 8847 Riverside Pkwy, Bryan, TX 77807, USA.
Andrea Martinez AguirreDepartment of Biology, Texas A&M University, 424 Nagle St, College Station, TX 77840, USA.
Mauricio LasagnaDepartment of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, TX 77843, USA.
Marko BalohDepartment of Biology, Texas A&M University, 424 Nagle St, College Station, TX 77840, USA.
Joseph A SorgDepartment of Biology, Texas A&M University, 424 Nagle St, College Station, TX 77840, USA.
Cecilia TommosDepartment of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, TX 77843, USA.
Zhilei ChenDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, 8847 Riverside Pkwy, Bryan, TX 77807, USA.ORCID 0000-0002-0244-3556

Funding

Understanding Protein RadicalsR01GM079190 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI TOMMOS, CECILIA · 2008 to 2024
$3.6M
Oral Protein Therapeutics Against C. difficile Associated ColitisR56AI155917 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI CHEN, ZHILEI, SORG, JOE · 2021 to 2021
$748k
NIGMS NIH HHS R01 GM079190NIH HHS R01GM079190
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35368085
PMCPMC9081868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.